Eleven UCSF faculty members, representing medical disciplines as far ranging as breast cancer, Parkinson's disease and heart development research, were among scientists awarded funding today by the California Institute for Regenerative Medicine (CIRM) for human embryonic stem cell research.
Eight of the UCSF grants were awarded to scientists based at UCSF and three to researchers at the UCSF-affiliated J. David Gladstone Institutes.
The awards are the first grants to have been issued by the California agency for laboratory research. In April 2006, CIRM awarded its first round of competitive funds, for stem cell training programs at UCSF and other California universities. CIRM was established by voters in November 2004 to administer $3 billion for stem cell research over 10 years.
"These grants are an important step forward for the stem cell field," says Arnold Kriegstein, MD, PhD, director of the UCSF Institute for Regeneration Medicine. "They will support a broad range of research into the nature of human embryonic stem cells that simply hasn't been able to be carried out on a wide scale due to federal funding restrictions."
An exciting aspect of the funding mechanism, he says, is that it has drawn into the field a broad spectrum of top medical scientists who traditionally have not conducted research with human embryonic stem cells, in part due to the federal funding restrictions.
Read more at Jennifer O'Brien, UCSF News Services